Cks Pharma Labs Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.37 Cr
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 7.83 Cr
- Revenue Growth -53.20%
- Profit Growth -634.99%
- Ebitda -213.88%
- Net Worth -165.27%
- Total Assets -38.23%
About Cks Pharma Labs
Cks Pharma Labs Private Limited (CPLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 August 2010 and has a history of 14 years and six months. Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.37 Cr.
The company currently has active open charges totaling ₹7.83 Cr.
Kishore Sudulagunta, Koduri Krishnaiah, Baba Ravavarapu, and One other member serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100AP2010PTC069851
-
Company No.
069851
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Aug 2010
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Cks Pharma Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bandaru Rao
|
Managing Director | 06-Jan-2016 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Baba Ravavarapu
|
Director | 10-May-2013 | Current |
|
Kishore Sudulagunta
|
Director | 06-Aug-2010 | Current |
|
Koduri Krishnaiah
|
Director | 10-May-2013 | Current |
Financial Performance of Cks Pharma Labs.
Cks Pharma Labs Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 53.2% decrease. The company also saw a substantial fall in profitability, with a 634.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 165.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cks Pharma Labs?
In 2021, Cks Pharma Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sri Rama Carriers Private LimitedKishore Sudulagunta is a mutual person
-
Surya Pragati Infrastructure Private Limited
Kishore Sudulagunta is a mutual person
-
Vb Multichem Private Limited
Bandaru Rao is a mutual person
-
Pharmasyn Drugs & Intermediates Private Limited
Bandaru Rao is a mutual person
Charges (Loans)
₹7.83 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 7.83 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2013 | Others | ₹7.83 Cr | Open |
How Many Employees Work at Cks Pharma Labs?
Cks Pharma Labs has a workforce of 8 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cks Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cks Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
